Skip to main content
OpenTrials

Clinical trial condition

Epithelial Tumor

Explore clinical trials studying Epithelial Tumor. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Epithelial Tumor trial results

Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Completed

Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)

NCT05165433

Conditions
Carcinoma, Epithelial Tumor, Metastatic Cancer, +7 more
Locations
  • Providence Medical Foundation Santa Monica, California, United States
  • UCLA Santa Monica, California, United States
  • Moffitt-Advent Health Clinical Research Unit Celebration, Florida, United States
  • Perelman Center of Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours

NCT05043714

Conditions
Carcinoma, Epithelial Tumor, Metastatic Cancer, +7 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA Department of Medicine Santa Monica, California, United States
  • Moffitt-Advent Health Clinical Research Unit Celebration, Florida, United States
  • University of Cincinnati Cancer Center Cincinnati, Ohio, United States
View Trial Details
Completed

First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector

NCT04053283

Conditions
Carcinoma, Epithelial Tumor, Infections, +9 more
Locations
  • University of Southern California (USC) - Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Santa Barbara, California, United States
  • Moffitt-Advent Health Clinical Research Unit Celebration, Florida, United States
  • Ochsner Medical Center (OMC) - The Gayle and Tom Benson Cancer Center New Orleans, Louisiana, United States
View Trial Details
Completed

First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody)

NCT03852511

Conditions
Carcinoma, Epithelial Tumor, Infections, +9 more
Locations
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

NCT02636036

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +21 more
Locations
  • University of Arizona Cancer Center, 1515 North Campbell Ave. Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center, 1500 E Duarte Str. Duarte, California, United States
  • UCLA Medical Center, 10945 Le Conte Ave, Ste. 3360 Santa Monica, California, United States
  • Horizon Oncology Research, 1345 Unity Place, Suite 365 Lafayette, Indiana, United States
View Trial Details

Related conditions